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etter to the editorycobacterium tuberculosis meningitis as the ﬁrst
resentation of chronic granulomatous diseaseear Editor,
hronic granulomatous disease (CGD) is one of the most com-
on genetic disorders of phagocytic functions, resulting from
efective generation of the respiratory burst in human.1,2
erein is described the case of a patient who was referred
o this center with tuberculous meningitis (TBM), where upon
urther investigation during the course of disease conﬁrmed
he underlying diagnosis of CGD.
A 3 year-old girl was admitted to a general hospital inWest-
rn Iran due to persistent fever and chills that had lasted for
hree weeks. After an initial diagnosis of fever of unknown
rigin (FUO), laboratory testing was performed (Table 1).
rythrocyte sedimentation rate (ESR) and C-reactive protein
CRP) were both elevated. Hepatic enzymes were slightly
ncreased. The patient had hypochromic microcytic anemia
Hb=10g/dL, MCV=69, MCH=22.9, reticulocyte = 1.8%). Chest
-ray revealed two calciﬁed lymph nodes in the right axillary
egion, ipsilateral to the site of the bacillus Calmette-Guérin
BCG) vaccination.
Broad-spectrum antibiotics, such as vancomycin and cef-
riaxone, were administered. However, the patient developed
eadache and vomiting. Following atonic seizures, she was
oved to the intensive care unit (ICU). Phenobarbital and
henytoinwere given to thepatient. Lumbar puncture (LP)was
erformed due to suspicion of meningitis. Cerebrospinal ﬂuid
CSF) examination revealed pleocytosiswithpredominanceof
olymorphonuclears (PMNs) (Table 1), while the presence of
wo acid-fast bacilli was reported in the CSF. Four drugs were
dded to the treatment protocol: isoniazid, rifampin, pyrazi-
amide, and ethambutol.
Due to persistent vomiting, fever, deterioration of the
ealth status, and non-compliance of the patient with the
reatment, the patient was referred to the Children’s Medical
enter, Pediatrics Center of Excellence, in Tehran, Iran. The
aboratory tests were repeated, and a new LP was performed,
hich revealed lymphocytic pleocytosis with presence of
hree acid-fast bacilli (Table 1). The protein and glucose pro-
les of the CSF were consistent with TBM. Regarding the LP,
nti–tuberculosis (anti-TB) agents were given to the patientwith the addition of streptomycin instead of pyrazinamide,
and vancomycin and ceftriaxone were discontinued. Com-
puted tomography (CT) scan showed a mild ventriculomegaly;
obstructive hydrocephaly due to the TBMwas suggested based
on these ﬁndings. Dexamethason and acetazolamide were
given to reduce the meningeal inﬂammation.
Due to the suspicion of immunodeﬁciency, immunologic
laboratory testswere performed. Immunoglubins and comple-
ment, anti-tetanusandanti-diphtheria seroprotection titers,
and B- and T-cell enumeration were all in normal range.
The phagocytic cell function was tested with a nitroblue-
tetrazolium (NBT) slide test, which was defective. NBT was
repeated and ﬂow cytometric dihydrorhodamine 123 (DHR)
assay was also performed, and the results were compatible
with the diagnosis of CGD. Then, the patient was treated
with interferon- as well as co-trimoxazole and itraconazole
as prophylactic antibiotics and antifungals. After ﬁve days,
symptoms including fever improved, except for headache and
vomiting. Due to consistent headache, a ventriculoperitoneal
shunting was performed, resulting in dramatically improve-
ment of headache and vomiting. After three days, fever and
all of the symptoms improved; the patient was discharged
with good condition. Anti-TB drugs were continued for nine
months, while the patient was prescribed INF- and prophy-
lactic antifungals and antibiotics.
Patients with CGD are prone to life-threatening bacte-
rial and fungal infections due to a defect in intracellular
elimination of microorganisms. NADPH oxidase complex of
phagocytic cells is a very important component in the defense
against catalasepositive bacteria suchas Staphylococcus aureus,
Serratia marcescens, and Aspergillus spp. However, the suscepti-
bility to mycobacterial infections has always been questioned.
Although experimental studies have demonstrated no dif-
ference between neutrophils of CGD patients and healthy
subjects in destroying M. tuberculosis, recent studies have
showed more evidence of the possible role of oxidative burst
3in host defense against mycobacterial infections.
The diagnosis of TBM is challenging, especially in patients
with underlying immunodeﬁciency. In the present case, the
CGD diagnosis had an important role in successful treatment,
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Table 1 – Laboratory ﬁndings of the chronic granulomatous disease patient with tuberculous meningitis.
Early tests at 1st hospital Repeated tests at this hospital Normal range
WBC 12,600/L 11,200/L 4,500-11,000/L
Hemoglobin 10 g/dL 10.1 g/dL 13.5-17.0 g/dL
C-reactive protein(CRP) 42 mg/dL 48 mg/dL 0-1.2 mg/dL
Erythrocyte sedimentation rate (ESR) 85 mm/h 101 mm/h 0-20 mm/h
Aspartate aminotransferase (AST) 45 U/L 133 U/L 10-60 U/L
Alanine aminotransferase (ALT) 43 U/L 98 U/L 5-45 U/L
Creatinin 0.4 mg/dL 0.4 mg/dL 0.6-1.2 mg/dL
Albumin 3.4 g/dL 3.3 g/dL 3.7-5.6 g/dL
Cerebrospinal ﬂuid
WBC 30/L (80% PMN) 133/L (80%Lymph) 0-3/L
r
1
2
3
4
5Glucose 38 mg/dL
Protein 48 mg/dL
although delayed. Unfortunately, physician unawareness is
still an obstacle to timely diagnosis.4 There were some alert-
ing clues for the suspicion of CGD, which should have been
noted. History of unknown deaths in the family and consan-
guinity of parents should alert the physicians for possible
primary immunodeﬁciency, as the results of misdiagnosis can
be devastating.5 Prompt diagnosis of underlying immuno-
deﬁciency and appropriate treatments are the key elements
that can save immunodeﬁcient patients and avoid irreversible
organ damage and death.
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